CSL Continues to Advance R&D Capabilities

SYDNEY, Australia – CSL Limited (ASX:CSL; USOTC:CSLLY) is gradually improving its Research & Development (R&D) pipeline and capabilities to deliver a greater range of products that will meet the standards of patients’ needs, according to Head of Research & Development Dr. ...